JM

Jamirahamad Mohamadhusen Patel

Active Director Designated Partner DIN 10038160
DIN 10038160 First appointment Jan 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jamirahamad Mohamadhusen Patel

Data last updated:

Jamirahamad Mohamadhusen Patel is a Designated Partner at Colvalcar Pharma Llp (since 2023). The company operates in Business Services.

DIN 10038160
Primary Designation Designated Partner
Industry Business Services
First Appointment 11 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Jan 20232023Active

Board colleagues of Jamirahamad Mohamadhusen Patel

NameDINCompanyDesignation
Rajesh Suresh Colvalkar00319374Colvalcar Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Colvalcar Pharma Llp
Premium access

Shareholding and investment profile for Jamirahamad Mohamadhusen Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jamirahamad Mohamadhusen Patel

Jamirahamad Mohamadhusen Patel currently holds 1 directorship: Colvalcar Pharma Llp (Designated Partner, since 11 Jan 2023).

Jamirahamad Mohamadhusen Patel was first appointed on 11 Jan 2023 as Designated Partner at Colvalcar Pharma Llp.

The current boards of Jamirahamad Mohamadhusen Patel's companies include Rajesh Suresh Colvalkar (Colvalcar Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available